This old-timer features a lot of modifications inside and out and beneath the skin, and is for sale in the United States with a clean Utah title ...
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2025.
The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...
MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
The abrupt closure of the nation’s largest book vendor to public libraries has forced them to scramble to find alternative sources of material and adjust how they acquire books. Baker & Taylor, a ...
Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved ...
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...
Consumer platforms like Amazon have trained B2B buyers to expect the same level of personalization and clarity in their business transactions. A report from Sana Commerce shows that 73% of respondents ...
If you’ve spent any amount of time playing online poker in the US, you’ll have come across Ignition Poker. Established back in 2016, it has cemented itself as one of the best and most popular ...
James Chen, CMT is an expert trader, investment adviser, and global market strategist. Andy Smith is a Certified Financial Planner (CFP®), licensed realtor and educator with over 35 years of diverse ...
It's as simple as moving a slider, but did you know that you can set a different volume level for each Mac app? Pranay Parab is an independent tech journalist based in Mumbai, India. He covers tech ...
MSD says it has a “line of sight to over $70bn” in potential commercial opportunity by the mid-2030s. HJBC via Shutterstock.com. Despite posting strong results in the final quarter of 2025, MSD (Merck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results